12,372 trials
Osteoarthritis
Primary: Least Squares Mean (Standard Error) [LS-mean (SE) ] Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at…
Nonsmall Cell Lung Cancer · NSCLC
Primary: Overall Survival of Patients Treated With TTFields + Docetaxel or Immune Checkpoint Inhibitors vs. Docetaxel or Immune Checkpoint Inhibitors Alone (Superiority Analysis)…
Follicular Lymphoma
Primary: Progression-Free Survival (PFS) as Assessed by Investigator — 42.02; 32.76 months — p=0.0231
Dry Eye Disease
Primary: Percentage of Subjects With Ocular Treatment-Emergent Adverse Events Attributed to Study Intervention — 0; 3.6 percentage of subjects
Respiratory Syncytial Virus Infections
Primary: Number of Maternal Participants With Pregnancy Outcomes From Conception Until Day 42 Post-delivery of the First Pregnancy Conceived Within 2 Years Post-vaccination…
Generalized Pustular Psoriasis
Primary: Percentage of Patients Achieving a GPPPGA Score of 0 (Clear) or 1 (Almost Clear) — 8; 8; 2 Participants
Pneumococcal Infection
Primary: Percentage of Participants With Solicited Injection-site Adverse Events (AEs) — 24.3; 16.4; 67.7; 54.5 Percentage of Participants
Muscular Dystrophy, Duchenne · Muscular Dystrophies · Muscular Disorders, Atrophic
Primary: DB Period: Change From Baseline in 6-Minute Walk Distance (6MWD) at Week 72 - Modified Intention-to-treat (mITT) Population — -81.83; -90.09 meters — p== 0.3626
Acute Kidney Injury
Primary: Number of Participants With Acute Kidney Injury — 54; 55 Participants
Short Cervical Length
Primary: Number of Participants With Delivery or Fetal Loss of Either Twin Prior to 35 Weeks Gestation — 84; 84; 86 Participants
Urinary Tract Infection · Acute Pyelonephritis
Primary: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit in the Microbiological Intent-to-Treat (Micro-ITT) Population — 261; 291; 171; 179…
Local Anesthetic
Primary: Conjunctiva Anesthesia With Chloroprocaine 3% Eye Gel as Compared With Oxybuprocaine Chlorhydrate 0.4% Eye Drops — 19; 23 participants
Bullous Pemphigoid
Primary: Percent of Participants Achieving Sustained Remission at Week 36 — 4.0; 18.2 Estimated Percentage of Participants — p=0.0250
Pharmacokinetics · Pharmacodynamics
Primary: Maximum Serum Insulin Aspart Concentration, CIAmax — 2961.8; 2827.4 pg/mL
Lung Diseases, Interstitial
Primary: Number of Patients With Treatment-emergent Adverse Events (AEs) Over the Whole Trial — 53 Participants